Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print November 14, 2007
DOI: 10.2337/db07-0993

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db07-0993v1
57/2/415    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riboulet-Chavey, A.
Right arrow Articles by Rutter, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riboulet-Chavey, A.
Right arrow Articles by Rutter, G. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Inhibition of AMP-activated protein kinase protects pancreatic ß-cells from cytokine-mediated apoptosis and CD8+ T cell-induced cytotoxicity

Audrey Riboulet-Chavey1, Frédérique Diraison1, L. Khai Siew2, F. Susan Wong2, and Guy A. Rutter1

1 Department of Cell Biology, Division of Medicine, Sir Alexander Fleming Building, Imperial College, London, Exhibition Road, London SW7 2AZ, UK
2 Dept. of Cellular & Molecular Medicine, University of Bristol, School of Medical Sciences, Bristol, BS8 1TD, UK

Objective: Apoptotic destruction of insulin-producing pancreatic ß-cells is involved in the aetiology of both type 1 and type 2 diabetes. AMP-activated protein kinase (AMPK) is a sensor of cellular energy charge whose sustained activation has recently been implicated in pancreatic ß-cell apoptosis and in islet cell death post-transplantation. Here, we examine the importance of ß-cell AMPK in cytokine-induced apoptosis and in the cytotoxic action of CD8+ T cells.

Research Design and Methods: Clonal MIN6 ß-cells or CD1 mouse pancreatic islets were infected with recombinant adenoviruses encoding enhanced green fluorescent protein (eGFP/Null), constitutively-active AMPK (AMPK CA), or dominant-negative AMPK (AMPK DN) and exposed or not to tumour necrosis factor-{alpha} (TNF-{alpha}), interleukin-1ß (IL-1ß) and interferon-{gamma} (IFN-{gamma}). Apoptosis was detected by monitoring the cleavage of caspase-3 and DNA fragmentation. The cytotoxic effect of CD8+ purified T cells was examined against pancreatic islets from NOD mice infected with either Null or the AMPK DN-expressing adenoviruses.

Results: Exposure to cytokines, or expression of AMPK CA, induced apoptosis in clonal MIN6 ß-cells and CD1 mouse pancreatic islets. By contrast, over-expression of AMPK DN protected against the proapoptotic effect of these agents, in part by preventing decreases in cellular ATP, and lowered the cytotoxic effect of CD8+ T cells towards NOD mouse islets.

Conclusions: Inhibition of AMPK activity enhances islet survival in the face of assault by either cytokines or T cells. AMPK may therefore represent an interesting therapeutic target to suppress immune mediated ß-cell destruction, and may increase the efficacy of islet allografts in Type 1 diabetes.


Correspondence: g.rutter{at}imperial.ac.uk


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.